Sunday, January 30, 2011

A.M. Vitals: Lilly Profit Beats Analysts? Expectations (By a Penny)

Also: the FDA says no to Avodart as a prostate cancer preventive; WellPoint looks to diversify; Berwick renominated.


Source: http://feedproxy.google.com/~r/wsj/health/feed/~3/MzgFpkqRsEA/

white teeth athletes health migraines

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)